Medical News

RSS

Consuming dried plums can protect from radiation-induced bone loss

Dr. Nancy Turner, a Texas A&M AgriLife Research scientist in College Station, was one of a team of researchers who recently studied different interventions to protect from radiation-induced bone loss.

23 Feb 2016

Study identifies new mechanism for controlling HIV replication

Researchers at University of California, San Diego School of Medicine have discovered that HIV infection of human immune cells triggers a massive increase in methylation, a chemical modification, to both human and viral RNA, aiding replication of the virus.

23 Feb 2016

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.

23 Feb 2016

Maternal supplementation with docosahexaenoic acid improves fetal iron metabolism

A research has proven, for the first time, that maternal supplementation with docosahexaenoic acid (DHA), an omega-3 essential polyunsaturated fatty acid, enhances fetal iron metabolism thanks to a greater expression of key genes regulating its transfer through the placenta.

23 Feb 2016

Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.

23 Feb 2016

PharmaEssentia to present results of P1101 + ribavirin phase II trial in HCV patients at APASL 2016

PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).

22 Feb 2016

BCRF expands research program with new collaborative breast cancer funding model

The Breast Cancer Research Foundation announced the expansion of its research program with a new collaborative breast cancer funding model—the BCRF Investigator-Initiated Drug Research Program—that will help broaden and accelerate clinical research on treatment strategies for people with breast cancer.

22 Feb 2016

ResMed announces definitive agreement to acquire Brightree

ResMed, the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced a definitive agreement to acquire privately held Brightree, a leader in business management and clinical software applications for the post-acute care industry.

From ResMed Corp 22 Feb 2016

MRI for unwitnessed stroke looking promising

Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.

22 Feb 2016

Astellas, Medivation announce acceptance of XTANDI sNDA for review by FDA

Astellas Pharma Inc. and Medivation, Inc. today announced that the U.S. Food and Drug Administration has accepted for review a supplemental New Drug Application (sNDA) that they have submitted for XTANDI (enzalutamide) capsules in metastatic castration-resistant prostate cancer (mCRPC), which includes findings from the Phase 2 TERRAIN and STRIVE studies, to update the relevant clinical sections within the current indication.

22 Feb 2016

Increasing medication adherence: an interview with Dr Alejandro (Alex) Jaimes

Adherence applies to multiple levels of healthcare. Before a drug goes on the market it has to undergo testing in clinical trials: participants take the study drug and report how well the drug works, along with any side effects.

22 Feb 2016

FDA approves Lannett's ANDA for Sumatriptan Nasal Spray USP

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray, the therapeutic equivalent to the reference listed drug Imitrex Nasal Spray, of GlaxoSmithKline.

22 Feb 2016

Survey: 76% of Americans agree that all doctors should be using digital technology for patients' records

Decades ago doctors made house calls and would trek to patients' homes in the worst of weather to care for patients. Well, those days have passed and we are in a new era when it comes to healthcare.

22 Feb 2016

Researchers examine socio-ecology, climate responses of Zika virus transmission

Zika: The virus has emerged as a major public health threat that's rapidly spreading through South and Central America and the Caribbean.

22 Feb 2016

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.

22 Feb 2016

Study show associations between general practice characteristics and premature mortality in England

General practitioner numbers appear to have a small but important influence on premature mortality rates in England, according to research by the University of Leicester.

22 Feb 2016

Diabetes researchers develop novel technique to monitor insulin resistance

Diabetes researchers at Sweden's Karolinska Institutet have developed a novel technique that makes it possible to monitor insulin resistance in a non-invasive manner over time in mice. The new method, presented in the journal Scientific Reports, can be used to assess insulin resistance during progression and intervention of metabolic diseases.

22 Feb 2016

Researchers investigate effect of naturally-derived pigment ASX on hippocampal function

With the recent rise in popularity of naturally-derived supplements to maintain a healthy body, there has been a great deal of attention toward development of the so-called "brain foods", which can enhance brain function. Of particular importance is the natural red pigment astaxanthin (ASX) abundant in both salmon and in crustaceans such as shrimp and crab.

22 Feb 2016

Researchers explore how E. coli survives in the presence of effective predatory bacteria

The majority of disease-causing bacteria in the body are rendered harmless by the protective effects of the immune system. Those that manage to escape the immune system can be killed by antibiotics, but bacteria are becoming more and more resistant to more and more antibiotics.

22 Feb 2016

ReCor gets FDA IDE approval to evaluate ReCor Paradise Renal Denervation System in patients with hypertension

ReCor Medical announced today that it has received FDA IDE approval for the RADIANCE-HTN clinical trial to evaluate the effect of the ReCor Paradise Renal Denervation System on blood pressure in patients with hypertension.

22 Feb 2016

Medical News

Consuming dried plums can protect from radiation-induced bone loss

Study identifies new mechanism for controlling HIV replication

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

Maternal supplementation with docosahexaenoic acid improves fetal iron metabolism

Regulus reports net loss of $7.2 million for fourth quarter 2015

PharmaEssentia to present results of P1101 + ribavirin phase II trial in HCV patients at APASL 2016

BCRF expands research program with new collaborative breast cancer funding model

ResMed announces definitive agreement to acquire Brightree

MRI for unwitnessed stroke looking promising

Astellas, Medivation announce acceptance of XTANDI sNDA for review by FDA

Increasing medication adherence: an interview with Dr Alejandro (Alex) Jaimes

FDA approves Lannett's ANDA for Sumatriptan Nasal Spray USP

Survey: 76% of Americans agree that all doctors should be using digital technology for patients' records

Researchers examine socio-ecology, climate responses of Zika virus transmission

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Study show associations between general practice characteristics and premature mortality in England

Diabetes researchers develop novel technique to monitor insulin resistance

Researchers investigate effect of naturally-derived pigment ASX on hippocampal function

Researchers explore how E. coli survives in the presence of effective predatory bacteria

ReCor gets FDA IDE approval to evaluate ReCor Paradise Renal Denervation System in patients with hypertension

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News